Abstract
Background: A group of patients who harbour the same highly transmissible strain of Pseudomonas aeruginosa were identified at a cystic fibrosis (CF) centre. Isolates of this strain display a number of unusual phenotypic features including resistance to most typical antipseudomonal antibiotics. A study was undertaken to see if there was a difference in treatment requirements between CF patients with chronic infection with their own unique P aeruginosa strains (group 1) and those who harbour a highly transmissible strain (group 2).
Methods: Data on treatment requirements for the year 2000 were collected from the case records of CF patients with chronic P aeruginosa infection who had received inpatient treatment. Patients co-infected with Burkholderia cepacia or other highly transmissible strains of P aeruginosa were excluded.
Results: There were 2/56 and 3/22 deaths in groups 1 and 2, respectively; these patients were excluded from the analysis. No difference was found between the two groups for mean age, % predicted forced expiratory volume in 1 second (FEV1), % predicted forced vital capacity (FVC), and body mass index. Patients in group 2 had a greater median (range) number of intravenous antibiotic days (60 (17–216) v 33 (4–237) days; p=0.01), inpatient days (39 (7–183) v 16 (1–172) days; p<0.01), and inpatient episodes (3 (1–9) v 2 (1–6); p<0.01), and more respiratory exacerbations (mean (SD) 8.2 (3.4) v 6.1 (3.2); p=0.01).
Conclusions: Patients who harbour the highly transmissible P aeruginosa strain have a greater treatment burden than patients with CF who harbour their own unique strains. These findings support the need for microbiological surveillance for highly transmissible P aeruginosa and the implementation of infection control measures to prevent cross infection.
Full Text
The Full Text of this article is available as a PDF (75.5 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Allen H. D., Thong I. G., Clifton-Bligh P., Holmes S., Nery L., Wilson K. B. Effects of high-dose inhaled corticosteroids on bone metabolism in prepubertal children with asthma. Pediatr Pulmonol. 2000 Mar;29(3):188–193. doi: 10.1002/(sici)1099-0496(200003)29:3<188::aid-ppul6>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
- Cheng K., Smyth R. L., Govan J. R., Doherty C., Winstanley C., Denning N., Heaf D. P., van Saene H., Hart C. A. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet. 1996 Sep 7;348(9028):639–642. doi: 10.1016/S0140-6736(96)05169-0. [DOI] [PubMed] [Google Scholar]
- Frederiksen B., Koch C., Høiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol. 1997 May;23(5):330–335. doi: 10.1002/(sici)1099-0496(199705)23:5<330::aid-ppul4>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
- Geddes D. M. Of isolates and isolation: Pseudomonas aeruginosa in adults with cystic fibrosis. Lancet. 2001 Aug 18;358(9281):522–523. doi: 10.1016/S0140-6736(01)05742-7. [DOI] [PubMed] [Google Scholar]
- Jones A. M., Govan J. R., Doherty C. J., Dodd M. E., Isalska B. J., Stanbridge T. N., Webb A. K. Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet. 2001 Aug 18;358(9281):557–558. doi: 10.1016/s0140-6736(01)05714-2. [DOI] [PubMed] [Google Scholar]
- Kerem E., Corey M., Gold R., Levison H. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. J Pediatr. 1990 May;116(5):714–719. doi: 10.1016/s0022-3476(05)82653-8. [DOI] [PubMed] [Google Scholar]
- McCallum S. J., Corkill J., Gallagher M., Ledson M. J., Hart C. A., Walshaw M. J. Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P aeruginosa. Lancet. 2001 Aug 18;358(9281):558–560. doi: 10.1016/s0140-6736(01)05715-4. [DOI] [PubMed] [Google Scholar]
- Pamukcu A., Bush A., Buchdahl R. Effects of pseudomonas aeruginosa colonization on lung function and anthropometric variables in children with cystic fibrosis. Pediatr Pulmonol. 1995 Jan;19(1):10–15. doi: 10.1002/ppul.1950190103. [DOI] [PubMed] [Google Scholar]
- Roseby R., Massie J. Pseudomonas infection in CF (cystic fibrosis). Thorax. 2000 Dec;55(12):1070–1071. doi: 10.1136/thorax.55.12.1070b. [DOI] [PMC free article] [PubMed] [Google Scholar]